申请人:Constellation Pharmaceuticals, Inc.
公开号:US20180290976A1
公开(公告)日:2018-10-11
Provided are novel compounds of Formula (I):
and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with LSD1. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with LSD1.